98 related articles for article (PubMed ID: 2441212)
1. Growth inhibitory polypeptides in the regulation of cell proliferation.
Keski-Oja J; Moses HL
Med Biol; 1987; 65(1):13-20. PubMed ID: 2441212
[TBL] [Abstract][Full Text] [Related]
2. Growth factors and cancer.
Goustin AS; Leof EB; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
4. From growth arrest to growth suppression.
Philipson L; Sorrentino V
J Cell Biochem; 1991 Jun; 46(2):95-101. PubMed ID: 1717501
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factors and control of neoplastic cell growth.
Keski-Oja J; Leof EB; Lyons RM; Coffey RJ; Moses HL
J Cell Biochem; 1987 Feb; 33(2):95-107. PubMed ID: 3553215
[TBL] [Abstract][Full Text] [Related]
6. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
Jacobsen SE; Ruscetti FW; Ortiz M; Gooya JM; Keller JR
Exp Hematol; 1994 Sep; 22(10):985-9. PubMed ID: 7522186
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
[TBL] [Abstract][Full Text] [Related]
8. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
[TBL] [Abstract][Full Text] [Related]
9. Peptide growth factors are multifunctional.
Sporn MB; Roberts AB
Nature; 1988 Mar; 332(6161):217-9. PubMed ID: 2831460
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression.
Jacobsen FW; Dubois CM; Rusten LS; Veiby OP; Jacobsen SE
J Immunol; 1995 Apr; 154(8):3732-41. PubMed ID: 7535812
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
Korc M; Haussler CA; Trookman NS
Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation.
Broide DH; Wasserman SI; Alvaro-Gracia J; Zvaifler NJ; Firestein GS
J Immunol; 1989 Sep; 143(5):1591-7. PubMed ID: 2527268
[TBL] [Abstract][Full Text] [Related]
13. [Transforming growth factor beta and fibroblast growth factor have opposite effects on the proliferation of endothelial cells].
Fràter-Schröder M; Müller G; Birchmeier W; Böhlen P
Schweiz Med Wochenschr; 1986 Aug; 116(34):1160-2. PubMed ID: 3464090
[TBL] [Abstract][Full Text] [Related]
14. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a hepatic proliferation inhibitor (HPI): effect of HPI on the growth of normal liver cells--comparison with transforming growth factor beta.
Huggett AC; Krutzsch HC; Thorgeirsson SS
J Cell Biochem; 1987 Dec; 35(4):305-14. PubMed ID: 3126196
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture.
McMahon JB; Richards WL; del Campo AA; Song MK; Thorgeirsson SS
Cancer Res; 1986 Sep; 46(9):4665-71. PubMed ID: 3089593
[TBL] [Abstract][Full Text] [Related]
17. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
Schwabe M; Cox GW; Bosco MC; Prohaska R; Kung HF
Cell Immunol; 1996 Feb; 168(1):117-21. PubMed ID: 8599834
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
Woodworth CD; Chung J; McMullin E; Plowman GD; Simpson S; Iglesias M
Cell Growth Differ; 1996 Jun; 7(6):811-20. PubMed ID: 8780894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
